β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer

MLA

Tenbaum, Stephan P., et al. “β-Catenin Confers Resistance to PI3K and AKT Inhibitors and Subverts FOXO3a to Promote Metastasis in Colon Cancer.” Nature Medicine, vol. 18, no. 6, June 2012, p. 892. EBSCOhost, https://doi.org/10.1038/nm.2772.

APA

Tenbaum, S. P., Ordonez-Moran, P., Puig, I., Chicote, I., Arques, O., Landolfi, S., Fernandez, Y., Herance, J. R., Gispert, J. D., Mendizabal, L., Aguilar, S., Y. Cajal, S. R., Schwartz, S., Vivancos, A., Espin, E., Rojas, S., Baselga, J., Tabernero, J., Munoz, A., & Palmer, H. G. (2012). β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer. Nature Medicine, 18(6), 892. https://doi.org/10.1038/nm.2772

Chicago

Tenbaum, Stephan P., Paloma Ordonez-Moran, Isabel Puig, Irene Chicote, Oriol Arques, Stefania Landolfi, Yolanda Fernandez, et al. 2012. “β-Catenin Confers Resistance to PI3K and AKT Inhibitors and Subverts FOXO3a to Promote Metastasis in Colon Cancer.” Nature Medicine 18 (6): 892. doi:10.1038/nm.2772.